Innovating Drug Design and Enzyme Engineering for Health and Industry

Arium Biolabs is an emerging biotechnology company dedicated to creating groundbreaking enzyme-based solutions to transform drug discovery, diagnostics, and biomanufacturing. Our work builds on more than 20 years of scientific research uncovering how enzymes function at a fundamental level. By integrating advanced computational tools with modern machine learning and artificial intelligence, we design novel technologies that accelerate time-to-discovery, enhance accuracy, and significantly reduce development costs.

Health Focus: Our long-term vision is to become a premier innovator of safer and more effective medicines. Today, we combine deep expertise in enzymology with state-of-the-art computational methods—including machine learning and artificial intelligence—to create next-generation biotherapeutics. Our strategy is centered on a synergistic combination of platform and product development: the platform is a proprietary enzyme-driven discovery engine, and the products are high-value enzyme-based therapeutics targeted to areas of critical medical need. This dual approach allows us to rapidly explore new opportunities while maintaining a strong focus on scientific rigor and clinical relevance.

Our IP portfolio: Arium Biolabs holds a robust and growing intellectual property portfolio, including four fully granted patents in the field of novel therapeutic discovery. These patents form the foundation of our competitive advantage and support the development of innovative enzyme-based medicines and technologies.